NCT00002402 - A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

BIOLOGICAL

MN rgp120/HIV-1 and GNE8 rgp120/HIV-1

BIOLOGICAL

MN rgp120/HIV-1 and A244 rgp120/HIV-1

BIOLOGICAL

Aluminum hydroxide

Trial Locations (4)

Johns Hopkins Bloomberg School of Public Health, Washington D.C.

Saint Louis Univ Health Sciences Ctr, St Louis

Dr Frank Judson / Director of Public Health Dept, Denver

Fenway Community Health Ctr, Boston